Skip to main content
Clinical Trials/NCT03655431
NCT03655431CompletedNot Applicable

Telerehabilitation Using Kinect-based VR to Improve Mobility and Fatigue in Veterans With MS

Shane.Chanpimol2 sites in 1 country10 target enrollmentStarted: October 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Multiple Sclerosis Walking Scale-12 (MSWS-12)

Study Overview

Brief Summary

The primary purpose of this study is to evaluate the effects of an individualized telerehabilitation program on mobility, fatigue, and quality of life for Veterans with MS. The secondary purpose was to assess adherence to exercise recommendations and overall satisfaction with the intervention.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical diagnosis of MS based on the McDonald criteria
  • Expanded Disability Status Scale (EDSS) of 3.0 - 6.5
  • Cognitive ability (Montreal Cognitive Assessment score >23/30)
  • Physician clearance for exercise participation
  • Physical therapy referral

Exclusion Criteria

  • MS-related exacerbation within last 3 months
  • Unstable cardiac or pulmonary disease
  • Active substance abuse
  • Uncontrolled seizures

Outcomes

Primary Outcomes

Multiple Sclerosis Walking Scale-12 (MSWS-12)

Time Frame: Change after 12-week intervention

This questionnaire has 12 items and measures self-reported walking ability in MS. The questions assess the limitations of a patient's walking due to MS during the past 2 weeks. Each item ranges from 1 to 5 and the higher the sum, the more severe the degree of limitation.

Secondary Outcomes

  • Short Physical Performance Battery (SPPB)(Change after 12-week intervention)
  • 25-Foot Walk Test (25FWT)(Change after 12-week intervention)
  • Veteran Rand 12 Quality of Life Measure (VR-12)(Change after 12-week intervention)
  • Modified Fatigue Impact Scale (MFIS)(Change after 12-week intervention)

Investigators

Sponsor
Shane.Chanpimol
Sponsor Class
Fed
Responsible Party
Sponsor Investigator
Principal Investigator

Shane.Chanpimol

Co-Investigator

Washington D.C. Veterans Affairs Medical Center

Study Sites (2)

Loading locations...

Similar Trials